AU2003261642A1 - Recombinant human herpes simplex virus for producing lentivirus vectors - Google Patents

Recombinant human herpes simplex virus for producing lentivirus vectors

Info

Publication number
AU2003261642A1
AU2003261642A1 AU2003261642A AU2003261642A AU2003261642A1 AU 2003261642 A1 AU2003261642 A1 AU 2003261642A1 AU 2003261642 A AU2003261642 A AU 2003261642A AU 2003261642 A AU2003261642 A AU 2003261642A AU 2003261642 A1 AU2003261642 A1 AU 2003261642A1
Authority
AU
Australia
Prior art keywords
recombinant human
herpes simplex
simplex virus
human herpes
lentivirus vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261642A
Inventor
Hui Cao
Xiaoyan Dong
Deyun Hou
Xiaobing Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGTC Gene Technology Co Ltd
Original Assignee
AGTC Gene Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGTC Gene Technology Co Ltd filed Critical AGTC Gene Technology Co Ltd
Publication of AU2003261642A1 publication Critical patent/AU2003261642A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16644—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003261642A 2002-09-10 2003-09-10 Recombinant human herpes simplex virus for producing lentivirus vectors Abandoned AU2003261642A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN02130619.2 2002-09-10
CNA021306192A CN1482239A (en) 2002-09-10 2002-09-10 Human recombinant herpes simplex virus for producing slow virus vector
PCT/CN2003/000765 WO2004024905A1 (en) 2002-09-10 2003-09-10 Recombinant human herpes simplex virus for producing lentivirus vectors

Publications (1)

Publication Number Publication Date
AU2003261642A1 true AU2003261642A1 (en) 2004-04-30

Family

ID=31983676

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261642A Abandoned AU2003261642A1 (en) 2002-09-10 2003-09-10 Recombinant human herpes simplex virus for producing lentivirus vectors

Country Status (3)

Country Link
CN (1) CN1482239A (en)
AU (1) AU2003261642A1 (en)
WO (1) WO2004024905A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004049290A1 (en) * 2004-10-09 2006-04-20 Bayer Healthcare Ag Process for the preparation of virus material
CN108611326B (en) * 2018-04-24 2019-07-19 高山 A kind of efficient lentivirus production system and its production method
CN111925998A (en) * 2020-06-09 2020-11-13 广州再生医学与健康广东省实验室 System for simulating SARS-CoV-2 infection and its preparation method and application
CN114478713B (en) * 2022-02-21 2023-03-28 江苏蒙彼利生物科技有限公司 CMV envelope protein packaging lentiviral vector and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716459B1 (en) * 1994-02-22 1996-05-10 Univ Paris Curie Host-vector system usable in gene therapy.

Also Published As

Publication number Publication date
WO2004024905A1 (en) 2004-03-25
CN1482239A (en) 2004-03-17

Similar Documents

Publication Publication Date Title
AU2003238456A1 (en) Viral vector
GB0206360D0 (en) Viral antigens
GB0206359D0 (en) Viral antigens
EP1494613A4 (en) Potent oncolytic herpes simplex virus for cancer therapy
AU2003285810A1 (en) Vision system
AU2003252137A1 (en) Intraocular lens system
EP1578782A3 (en) Combination therapy with co-stimulatory factors
AU2003267688A1 (en) Projection system
AU2002344798A1 (en) Lightweight armor plates
AU2003289742A1 (en) Stable therapeutic proteins
AU2003201727A1 (en) Recombinant protein expression
AU2003290563A1 (en) Leptin-related peptides
AU2003292405A1 (en) Cancer immunotherapy using polycomb proteins
AU2003217067A1 (en) Optical controls
AU2002363944A1 (en) Alpha-fetoprotein peptides and uses for imaging
AU2003225544A1 (en) Recombinant bovine immunodeficiency virus based gene transfer system
AU2003261642A1 (en) Recombinant human herpes simplex virus for producing lentivirus vectors
AU2002347813A1 (en) Chimeric viral vectors for gene therapy
AU2003228863A1 (en) Immunogenic peptides
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003230364A1 (en) Gun mirror
AU2003214299A1 (en) Hiv-1 virus tat-protein mutants
AU2003272727A1 (en) Diagnosis of bovine viral diarrhea virus
AU2002952524A0 (en) Epstein barr virus peptide epitopes
AU2003276846A1 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase